Clinical Trials Directory

Trials / Completed

CompletedNCT00858143

Non Interventional Study For Patients Treated With Somavert®

German Non Interventional Study For Patients Treated With Somavert®

Status
Completed
Phase
Study type
Observational
Enrollment
311 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This open-label, national, prospective, observational, non-interventional, multi-center, post marketing surveillance study was performed in order to examine the efficacy and safety of Somavert® in treatment of subjects with acromegaly and its effects on acromegaly related co-morbidities.

Detailed description

Non probability samples

Conditions

Interventions

TypeNameDescription
OTHERNon Interventional ObservationPost marketing surveillance study = prospective, non-interventional observation of the use of Somavert®

Timeline

Start date
2004-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2009-03-09
Last updated
2009-09-02
Results posted
2009-08-12

Source: ClinicalTrials.gov record NCT00858143. Inclusion in this directory is not an endorsement.

Non Interventional Study For Patients Treated With Somavert® (NCT00858143) · Clinical Trials Directory